NCT05936125

Brief Summary

Functional tricuspid regurgitation (FTR) remains a common finding in patients with left-sided valvular heart diseases especially mitral valve regurgitation or stenosis. It is mainly caused by dilatation and flattening of the tricuspid valve (TV) annulus as a result of right ventricular (RV) enlargement and is inevitably affected by the RV function. Multiple studies support the better outcome of using rigid ring annuloplasty over suture repair for treating FTR in concern with the durability and freedom from residual regurgitation. These studies refer the superiority of rigid ring annloplasty to the three-dimensional configuration achieved by such rings which matches the normal tricuspid annulus and, at the same time, to the rigid support of the annulus. On the other hand, other studies support the use of flexible prosthetic bands like Dacron or polytetrafluroethilin (PTFE), especially over suture techniques, due to their easy applicability and availability with good postoperative results. Therefore, suture annyloplasty became nowadays less convenient for FTR repair since both flexible bands and rigid rings appeared to offer good midterm outcomes in recent meta-analysis studies. However, the ideal annuloplasty method for repairing FTR is still debatable between the three-dimensional (3D) rigid rings versus flexible prosthetic bands. In this retrospective comparative study, we share our experience with flexible fashioned bands in FTR.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

July 7, 2023

Status Verified

June 1, 2023

Enrollment Period

1 year

First QC Date

April 22, 2023

Last Update Submit

June 28, 2023

Conditions

Keywords

Tricuspid ValveTricuspid Valve RegurgitationTricuspid Valve Annuloplasty

Outcome Measures

Primary Outcomes (1)

  • Tricuspid valve regurgitation

    Using Echocardiography to asset tricuspid valve regurgitation

    1 year post operative

Secondary Outcomes (1)

  • Tricuspid Annular Plane Systolic Excursion (TAPSE)

    1 year post operative

Study Arms (1)

Patients with tricuspid valve regurgitation undergoing open heart surgery

EXPERIMENTAL

Patients undergoing open heart surgery (for any reason) with concomitant tricuspid valve regurgitation

Other: Annuloplasty Using Flexible Band

Interventions

Tricuspid valve annuloplasty using a flexible band; (Polyethylene terephthalate band): (Dacron band)

Patients with tricuspid valve regurgitation undergoing open heart surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients presented at Assiut University Hospital with tricuspid valve regurgitation

You may not qualify if:

  • Age less than 18 years old.
  • Tricuspid valve stenosis.
  • Organic tricuspid valve disease.
  • Infective endocarditis on tricuspid valve.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Hospital University

Asyut, Egypt

Location

MeSH Terms

Conditions

Heart Valve DiseasesTricuspid Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Mahmoud Kamel Mohamed Sayed

Study Record Dates

First Submitted

April 22, 2023

First Posted

July 7, 2023

Study Start

August 1, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

July 7, 2023

Record last verified: 2023-06

Locations